The Neuropathy subspecialty concerns the diagnosis and management of different types of acquired and hereditary neuropathies.
Key diagnostic areas within neuropathies include clinical, electrophysiological, genetic, immunological and histopathological diagnosis, as well as implementation of newer diagnostic methods in the field such as magnetic resonance imaging and ultrasound. Identification of diagnostic and prognostic biomarkers of different neuropathies is also urgently needed.
Another focus of the panel are available therapies and development of new therapies for acquired and hereditary neuropathies, including both causal therapy and symptomatic therapy to improve patients’ quality of life and their wellbeing. Main areas of interest are inflammatory and hereditary neuropathies. The panel also takes care of other causes of neuropathies such as diabetic, metabolic, alcoholic, nutritional, infectious etc.
Since polyneuropathies may be a part of the clinical presentation and/or secondary to other diseases, the Scientific Panel on Neuropathies have tight collaboration with other EAN panels and with other specialists outside neurology. Healthcare organisation and delivery is another topic where Panel would be glad to contribute to the future.
The neuropathies SP actively promotes and supports neuropathy-related issues, as well as educational and scientific activities within the framework of EAN.
The panel substantially contributes to the Scientific Programme at EAN congresses and other EAN educational activities. It develops clinical guidelines in collaboration with other associations, specifically with the Peripheral Nerve Society.
Group members are strongly encouraged to engage in the activities promoted by the panel and to contribute to the sharing of advances in the field of neuropathies via the Breaking News, Neurology Update, and eLearning sections of the EAN website, and to engage in the activities promoted by the panel.
The panel meets during the EAN congress.